EU-backed projects join forces to tackle obesity crisis

Over the past decades, obesity has reached epidemic proportions, now affecting more than 1 billion people worldwide.

Mindbio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial | Psychedelic Invest

TerXT is a combination of xanomeline and trospium prodrugs for the treatment of schizophrenia, and intends to pursue accelerated 505(b)(2) approval pathway Miami, FL –

June 12, 2024

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The

June 20, 2023

Emergency Medicine Group Claims Credit for Envision’s California Exit

Envision Healthcare, the physician staffing firm that emerged from bankruptcy late last year, is exiting its California operations — and one physician organization believes their

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.